Bone marrow transplantation in accelerated chronic granulocytic leukaemia using dibromomannitol-preconditioning instead of total-body irradiation-Reference-Cited by-同舟云学术

Bone marrow transplantation in accelerated chronic granulocytic leukaemia using dibromomannitol-preconditioning instead of total-body irradiation

Published:1985-01 Issue:8 Volume:9 Page:1009-1015
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Kelemen Endre,Janossa Margit,Triska Éva,Szalay Ferenc,Váradi András,Magyar Tamás,Sellyei Mihály

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Myelobromol (DBM) lökéskezelés valódi polycythaemiában : tizenkét év tapasztalatai;Kelemen;Orv. Hetil.,1983

2. Stromal and hemopoietic stem cell abnormalities in longterm cultures from busulfan-treated mice;Hays;Expl. Hemat.,1982

3. Marrow transplantation for ANLL after treatment with busulfan and cyclophosphamid;Santos;New Engl. J. Med.,1983

4. Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors : critical review of syngeneic, autologous, and allogeneic transplants;Champlin;Cancer Treat. Rep.,1984

5. Other hematological malignancies;Messner,1983

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remarkably Reduced Transplant-Related Complications by Dibromomannitol Non-Myeloablative Conditioning before Allogeneic Bone Marrow Transplantation in Chronic Myeloid Leukemia;Acta Haematologica;2001

2. Changing Approaches to Transplant Conditioning for Hematologic Malignancy;Journal of Hematotherapy;1999-06

3. High-Performance liquid chromatographic determination of dibromomannitol in plasma;Chromatographia;1998-07

4. Graft-versus-Host Disease in Bone Marrow Transplantation: Experimental, Laboratory, and Clinical Contributions of the Last Few Years;International Archives of Allergy and Immunology;1993

5. Discordant neutrophil alkaline phosphatase activity and cytogenetic response in chronic myeloid leukemia treated with α-interferon;Pathology;1993